Yobyrine

• CAT Number: I038594
• CAS Number: 525-15-5
• Molecular Formula: C19H16N2
• Molecular Weight: 272.35
• Purity: 98%
• Synonyms: Yobyrine; NSC 108045; Yobirine
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 1-[(2-methylphenyl)methyl]-9H-pyrido[3,4-b]indole
• InChI: InChI=1S/C19H16N2/c1-13-6-2-3-7-14(13)12-18-19-16(10-11-20-18)15-8-4-5-9-17(15)21-19/h2-11,21H,12H2,1H3
• InChIKey: LQCWIBNVYWPLIU-UHFFFAOYSA-N
• SMILES: CC1=CC=CC=C1CC2=NC=CC3=C2NC4=CC=CC=C34

Yobyrine（Cat No.:I038594）is a novel, investigational drug developed by Yobyrine Pharmaceuticals. It is primarily being researched for its potential in treating neurological and psychiatric conditions, such as Alzheimer’s disease and major depressive disorder. The drug works by targeting specific neurotransmitter systems in the brain to help regulate mood and cognitive function. Yobyrine is designed to enhance synaptic plasticity and support neuroprotection. Though still in the clinical trial phase, early research suggests it may offer a promising approach for conditions with limited treatment options, though its safety and efficacy need further evaluation.